Epstein David R Insider Trades & Stock Holdings

Director · AgomAb Therapeutics NV · Latest filing Oct 8, 2026

Epstein David R, Director at AgomAb Therapeutics NV has 3 Form 4 trades on file since Oct 5, 2026. Open-market activity: 3 purchases ($130.85K) and 0 sales ($0), net +$130.85K. Latest filing: acquired 5K shares of $AGMB on Oct 8, 2026 at $8.90.

Trades on file

3

Open-market bought

$130.85K

Open-market sold

$0

Net open-market

+$130.85K

Latest filing

Oct 8, 2026

All insider trades by Epstein David R

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 8, 2026	$AGMB	Buy (Open-market buy)	5K	$8.90	$44.50K			-9.7%			Director		—
Oct 6, 2026	$AGMB	Buy (Open-market buy)	5K	$8.70	$43.50K			-0.3%			Director		—
Oct 5, 2026	$AGMB	Buy (Open-market buy)	5K	$8.57	$42.85K			+4.6%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Epstein David R traded

• $AGMB

Frequently asked questions

Has Epstein David R been buying or selling stock?

Epstein David R has 3 open-market purchases and 0 open-market sales on file, net +$130.85K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Epstein David R's latest insider trade?

acquired 5K shares of $AGMB on Oct 8, 2026 at $8.90.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.